The Top Five Product Searches on CPHI Online: December

Which were the products that drew the most interest in the CPHI directory in December? We analyse search data from the CPHI directory…
1. Avoquin 4% - Avalon Pharma
Retaining its position at the top of the tree during the previous month, this skin lightening cream continues to attract the most interest on CPHI Online.
The formulation – sold in African, Middle Eastern and Asian markets -- contains hydroquinone, which the company describes as the ‘gold standard’ for treatment of skin hyperpigmentation and claims has been proven in clinical trials to be the safest and most effective skin lightening agent.
Skin lightening refers to the practice of using chemical substances to lighten the skin or provide an even skin colour by reducing the melanin concentration. Hydroquinone is currently not approved for this purpose in Europe.
2. Avocom-M cream – Avalon Pharma
This anti-inflammatory, antipruritic and anti-allergic cream, also from Avalon Pharma, crept up one place in December. The product is a unique combination of corticosteroid, Mometasone Furoate, (0.1% concentration) and anti-fungal Miconazole Nitrate (2%).
3. Avalon Avotin -Avalon Pharma
Last month, Avalon recorded three products in the top five; this month the young Saudi Arabian company has matched that, with the added bonus of them occupying all three podium positions. This formulation of Tretinoin cream, a derivative of vitamin A, was a new entry in December. It is a versatile retinoid that works by increasing the growth rate of skin cells and is used to treat a variety of skin conditions, from acne to aging.
4. Spasmo-Apotel (Paracetamol + Hyoscine Butylbromide) – Uni-Pharma
The month’s second new entrant comes from Greece’s Uni-Pharma and is a combination of hyoscine hydrobromide, taken to relieve stomach cramps, including those linked with irritable bowel syndrome, and painkiller, paracetamol.
5. Mycoten - Munir Sukhtian Group
Rounding off, the top five, this antifungal treatment slipped down three places from second position in November. The formulation, available in both tablets and cream, contains the active ingredient clotrimazole and is used for the relief of vaginal itching, burning, and discharge associated with vaginal yeast infections (vulvovaginal candidiasis).



Related News
-
News Accepting novel excipients for innovative drug development
With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News WHO calls on public for ideas to rename monkeypox
‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public -
News Chinese market represents ‘single greatest generational opportunity’ for Pharma
China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population. -
News Monkeypox Update: Vaccine shortage, sewage surveillance and global testing
As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August. -
News mRNA production partnership to scale-up COVID-19 vaccine development
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site. -
News The Data Revolution: How Real-World Evidence is Changing Pharma
A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance